基因 panel 与外显子组测序在胎儿异常中的比较
该研究为前瞻性队列的二次分析,纳入 109 例胎儿异常病例并接受外显子组测序(ES),评估 ES 检出的致病/可能致病变异中可被美国产前可用基因 panel 检出的比例。结果显示 20 例(18%)检出致病变异,panel 可检出其中 50 个(88%)变异;孤立性骨骼异常检出率最高(100%),多系统异常 panel 表现最差(50%)。
要点
- ES 在 109 例胎儿异常中检出 20 例(18%)致病变异。
- 基因 panel 可检出 ES 所检出变异的 88%(50 个)。
- panel 对多系统异常检出率仅 50%,低于孤立性异常。
核心结论
- 在 ES 检出遗传病因的胎儿异常病例中,商业基因 panel 的诊断率因异常类型而异,多系统异常时 panel 表现最差。
研究设计与样本
- 前瞻性队列研究的二次分析,纳入 109 例存在孤立或多系统骨骼发育不良、中枢神经系统异常和/或心脏异常的胎儿异常妊娠病例,均接受 ES 检测。
主要发现
- 109 例中 20 例(18%)检出致病/可能致病变异:多系统 4 例、孤立性中枢神经系统 4 例、孤立性心脏 6 例、孤立性骨骼发育不良 6 例。
- 基因 panel 可检出 ES 所检出变异中的 50 个(88%)。
- 孤立性骨骼异常 panel 检出率为 100%,高于中枢神经系统(75%)和心脏畸形(67%),P=0.02。
- 孤立性异常的 panel 检出率高于多系统异常(中位数 91.5% vs 50%,P<0.01)。
临床怎么用
- 对于胎儿多系统异常,基因 panel 可能漏检较多致病变异,应考虑 ES 作为更全面的检测策略。
- 对于孤立性骨骼异常,基因 panel 诊断率较高,可作为合理选择。
局限性
- 为二次分析,样本量 109 例,结果需在更大前瞻性队列中验证。
- 仅评估美国产前可用的商业基因 panel,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Exome sequencing (ES) and gene panels can be considered for fetal anomalies. Whether ES offers substantial benefit over targeted panels is not clear. METHODS: Secondary analysis of a prospective cohort study of pregnancies with fetal anomalies undergoing ES. We included cases with isolated or multisystem skeletal dysplasias, CNS anomalies, and/or cardiac anomalies. Participants underwent ES, and pathogenic (P) and likely pathogenic (LP) variants were reported. The primary outcome was the percentage of P/LP variants found on ES that would have been identified on panels available prenatally in the United States. RESULTS: 109 cases with relevant anomalies were included in the primary analysis. Of these, 20 (18%) had P/LP variant(s) identified on ES-4 multisystem, 4 isolated CNS, 6 isolated cardiac, and 6 isolated skeletal dysplasia. Gene panels would have detected 50 (88%) of the variants identified by ES. Yield was highest for isolated skeletal anomalies (100%) compared to CNS and cardiac malformations (75% and 67%, p = 0.02). Yield was higher for isolated anomalies than multisystem anomalies (median 91.5% vs. 50%, p < 0.01). CONCLUSIONS: In cases of fetal anomalies with genetic etiologies identified on ES, commercial gene panels had variable diagnostic yields. Panels performed worst for multisystem anomalies.
引用
- Swanson K, Shear MA, Sparks TN, et al. Gene Panel Versus Whole Exome Sequencing for Fetal Anomalies. Prenat Diagn. 2026. PMID: 41820793. doi:10.1002/pd.70118
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。